
### [MONDO:0019254](http://purl.obolibrary.org/obo/MONDO_0019254)
**Label:** disorder of purine or pyrimidine metabolism

**Subclasses:** [MONDO:0019238](http://purl.obolibrary.org/obo/MONDO_0019238) (disorder of pyrimidine metabolism), [MONDO:0018106](http://purl.obolibrary.org/obo/MONDO_0018106) (hereditary xanthinuria), [MONDO:0019236](http://purl.obolibrary.org/obo/MONDO_0019236) (disorder of purine metabolism), [MONDO:0010298](http://purl.obolibrary.org/obo/MONDO_0010298) (Lesch-Nyhan syndrome), [MONDO:0015253](http://purl.obolibrary.org/obo/MONDO_0015253) (Diamond-Blackfan anemia), [MONDO:0016088](http://purl.obolibrary.org/obo/MONDO_0016088) (hypoxanthine-guanine phosphoribosyltransferase deficiency), [MONDO:0010395](http://purl.obolibrary.org/obo/MONDO_0010395) (phosphoribosylpyrophosphate synthetase superactivity), [MONDO:0013028](http://purl.obolibrary.org/obo/MONDO_0013028) (adenosine monophosphate deaminase deficiency), [MONDO:0010699](http://purl.obolibrary.org/obo/MONDO_0010699) (Charcot-Marie-tooth disease X-linked recessive 5), 

**Corr. equiv. classes:** [Orphanet:45](http://www.orpha.net/ORDO/Orphanet_45), [Orphanet:124](http://www.orpha.net/ORDO/Orphanet_124), [Orphanet:99014](http://www.orpha.net/ORDO/Orphanet_99014), [OMIM:300661](http://purl.obolibrary.org/obo/OMIM_300661), [OMIM:300322](http://purl.obolibrary.org/obo/OMIM_300322), [OMIM:311070](http://purl.obolibrary.org/obo/OMIM_311070), [Orphanet:79191](http://www.orpha.net/ORDO/Orphanet_79191), [Orphanet:79193](http://www.orpha.net/ORDO/Orphanet_79193), [OMIM:612874](http://purl.obolibrary.org/obo/OMIM_612874), [Orphanet:3222](http://www.orpha.net/ORDO/Orphanet_3222), [Orphanet:510](http://www.orpha.net/ORDO/Orphanet_510), [Orphanet:206428](http://www.orpha.net/ORDO/Orphanet_206428), [Orphanet:3467](http://www.orpha.net/ORDO/Orphanet_3467), 

**Class expressions from DL-Learner:**

- Thing 34.65%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 34.65%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 30.56%
- [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 29.05%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) 28.34%
- [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 27.70%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) 27.31%
- [HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs) 24.53%
- [HP:0100022](http://purl.obolibrary.org/obo/HP_0100022) (Abnormality of movement) 21.84%
- [HP:0011442](http://purl.obolibrary.org/obo/HP_0011442) (Abnormality of central motor function) 21.41%
- [HP:0000079](http://purl.obolibrary.org/obo/HP_0000079) (Abnormality of the urinary system) 20.71%
- [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 20.54%
- [HP:0000119](http://purl.obolibrary.org/obo/HP_0000119) (Abnormality of the genitourinary system) 20.02%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) 19.75%
- [HP:0000924](http://purl.obolibrary.org/obo/HP_0000924) (Abnormality of the skeletal system) 19.08%


